BioCentury
ARTICLE | Company News

Intrexon, Genten deal

October 3, 2016 7:00 AM UTC

Intrexon granted newco Genten exclusive access to Intrexon’s ActoBiotics technology to deliver gluten peptide therapies to promote immune tolerance in patients with celiac disease. The ActoBiotics tec...